Physician profile
Steven M Passman
NPI 1770596512
$1,496.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,302 · 2020: $194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $275.25 | 2019-2020 | |
| Celgene Corporation | $230.10 | 2019 | |
| Abbvie INC. | $182.45 | 2019-2020 | |
| Janssen Biotech, INC. | $157.31 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $98.19 | 2019 | |
| Sun Pharmaceutical Industries INC. | $94.27 | 2019 | |
| Amgen INC. | $85.45 | 2019-2020 | |
| Genentech USA, INC. | $75.27 | 2019-2020 | |
| Prugen, INC. Pharmaceuticals | $67.55 | 2020 | |
| Aclaris Therapeutics, INC. | $56.94 | 2019 | |
| Galderma Laboratories, L.P. | $54.92 | 2019 | |
| Mayne Pharma Commercial LLC | $38.30 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.77 | 2019 | |
| Kyowa Kirin, INC. | $16.12 | 2020 | |
| Biofrontera INC. | $14.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Passman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.